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aBStraCt 
Introduction: Many cerebrovascular diseases display a relation with inflammatory processes. Furthermore, the influence of several 
polymorphisms has been studied to improve the knowledge of physiological mechanisms of the nervous system. Objectives: The aim of 
this study was to identify if there was an association between a polymorphism in -308 position of the TNFA gene and the development 
of hemorrhagic stroke or aneurysm in Distrito Federal, Brazil. Methods: We collected the clinical information and the medical records 
from hemorrhagic stroke or aneurysm patients. The occurrence of stroke or aneurysm was confirmed by computed tomography (CT) 
or magnetic resonance image (MRI). The TNFA genotypes were determined by polymerase chain reaction restriction fragment length 
polymorphism. Results: The AG genotype appears to decrease the occurrence of hemorrhagic stroke or aneurysm in people between 45-
63 years. Our study was the first to investigate this association in a Brazilian sample, although a previous report showed a similar effect 
with ischemic stroke in a Chinese population. Conclusion: The TNFA -308 AG genotype is associated with a decreased risk of aneurysm 
or hemorrhagic stroke in a population from the capital of Brazil, Distrito Federal.
Key words: tumor necrosis factor-alpha; single nucleotide polymorphism; stroke; intracranial hemorrhages; intracranial aneurysm. 
introDuCtion
Stroke is a major global health problem that imposes a huge 
socioeconomic burden(1). According to estimates of the World 
Health Organization (WHO), 6.7 million people died worldwide 
due to stroke(2) in 2015. Stroke is a leading cause of mortality 
and disability in Brazil and Latin America overall, probably in 
consequence of changes in the population lifestyle and increasing 
life expectancy(3).
Stroke is primarily classified into two types: ischemic (80%-
85% of cases) and hemorrhagic (15%-20% of cases). Given its 
multifactorial nature, stroke is related with hypertension, diabetes, 
atherosclerosis, genetic influences, among other factors(3-6).
It is well known that inflammatory factors are closely related 
with ischemic stroke and cerebrovascular diseases(7). Patients with 
stroke have shown an increase in pro-inflammatory cytokines 
concentrations in their serum and cerebrospinal fluid(8-10). 
Punctual factors, such as polymorphisms in promoter region of 
cytokine or cytokine receptor genes, might modulate the levels 
of its final product. Therefore, the TNFA polymorphisms could 
potentially influence the etiology of stroke. Even though some 
studies were conducted with this polymorphism in relation to 
other diseases, none were about hemorrhagic stroke (HS) or 
aneurysm(11, 12).
Tumor necrosis factor-α (TNF-α) is a pro-inflammatory 
cytokine common in the central nervous system. The human 
TNFA gene is mapped to chromosome 6p21.33(13), and it has two 
polymorphisms in its promoter regions, described at positions 
-308 (G/A) and -238(G/A). The one present at position -308 (G/A) 
has its A allele associated with higher levels of tumor necrosis 















factor (TNF) expression(14). A meta-analysis of 18 studies with 
8,075 patients found no significant association between ischemic 
stroke and TNFA-308G/A and TNFA-238G/A. However, the TNFA 
-308G/A demonstrates a protective factor against ischemic stroke, 
according to subgroup analysis of East Asians(15). Therefore, we 
oriented the study to TNFA-308G/A polymorphism. Among its 
functions, it activates proteolytic enzymes that damage endothelial 
cells, resulting in rupture of the aneurysm or HS(16). Through these 
effects, TNF-α may be involved in the pathogenesis of HS. Hence, 
this case-control study was conducted to investigate the effect of 
TNFA-308G/A (rs1800629) genetic variants on the development 
of HS/aneurysm in a Brazilian population.
MEthoDS
Subjects
This study composed of 162 individuals was conducted at 
Faculdade de Ceilândia of Universidade de Brasília (UnB), Brazil. 
The samples were obtained from a hospital-based case-control 
study completed in two years ( January, 2011 to December, 2012). 
A total of 81 patients diagnosed with aneurysm/HS (48 females 
and 33 males; mean age 54 ± 9 years) were recruited for this study. 
All patients had clinical signs consistent with the WHO definition 
of stroke and confirmed by imaging [computed tomography (CT) 
or magnetic resonance image (MRI)](17).
The control group comprised 81 (43 females and 38 males; 
mean age 52 ± 6 years) age- and sex-matched healthy individuals 
recruited from volunteers and healthy individuals accompanying 
the patients in the general outpatient department (OPD). The 
sample was calculated by estimating a prevalence of 20% of HS in 
the adult population, a sampling error of 5% and a 95% confidence 
interval (CI), in 112 patients evaluated according to the criteria 
previously described. A total of 78 participants were included. We 
considered a sample of 81 patients with HS in order to compensate 
for any loss.
Informed consent was obtained from all subjects before 
information collection. This study was approved by the 
institutional ethical committee. Participants under the age of 18 
without diagnosis of aneurism or stroke and parentage correlation 
with the control group were excluded.
Clinical characteristics
Detailed history was taken and clinical evaluation was done. 
Patients were questioned about having arterial hypertension 
(blood pressure was measured) or diabetes, current smoking, 
alcohol consumption. Scales were used to measure severity, 
stages of disease and incapacity of patients: Rankin scale (RS) for 
measurement of motor capacity(18), Barthel index (BI) score 
for mobility and personal cares(19), and the Glasgow scale for 
assessing the level of consciousness of the patient(20).
Laboratory methods
Each patient and control subject provided a 5 ml 
peripheral venous blood sample after enrollment. Genomic 
deoxyribonucleic acid (DNA) was extracted from peripheral 
blood using the Invisorb Spin Blood Mini Kit (250) by Invitek 
(catalog #CA10-0005, batch #1031100300). The genotyping of 
TNFA -308G/A (rs1800629) polymorphism was performed using 
polymerase chain reaction (PCR) combined with restriction 
fragment length polymorphism analysis. The forward and 
reverse primers used to amplify TNFA -308G/A (rs1800629) were 
5’-AGG CAA TAG GTT TTG AGG GCC AT-3’ and 5’-TCC TCC CTG 
CTC CGA TTC CG-3’, respectively. Amplification was performed 
using the following cycling program: an initial denaturation 
step at 95°C for 10 min, then 38 cycles of denaturation at 94°C 
for 1 min, annealing at 57°C for one minute, and extension 
at 72°C for one minute, followed by a final extension at 72°C 
for eight minutes. PCR products of 107 bp were subsequently 
incubated for 90 minutes at 37°C with NcoI. The G allele was 
cut into two fragments of 87 bp and 20 bp, while the A allele 
remained undigested. These fragments were visualized on a 
3.5% agarose gel stained with ethidium bromide and exposed 
to ultraviolet light.
Statistical analysis
The genotype and allele frequencies in HS patients were 
compared to those in control subjects using the chi-squared test 
in recessive and dominant models. The Armitage trend test was 
performed to see if there is a dosage effect in a risk allele for HS. An 
association of clinical features with each genotype was analyzed 
by the chi-squared. A p-value of less than 0.05 was considered 
significant.
rESuLtS
No significant difference was found between the control and 
case groups in terms of gender (p = 0.429) and age (p = 0.185). 
We analyzed the presence of TNFA -308G/A polymorphism in 
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the aneurysm case group when compared with the HS case 
group and the control group. No specific association was found 
(Table 1). Nevertheless, the AG genotype is associated with 
lower risk of aneurysm or HS [odds ratio (OR) = 0.35; 95% 
CI 0.13-0.96 (p = 0.035)] (Table 2). Secondly, the genotype 
distribution is not at Hardy-Weinberg equilibrium in the case 
group (p < 0.01).
taBLE 2 − Association of TNFA -308G/A (rs1800629) polymorphism 
with HS or aneurysm
Aneurysm/HS Control
n % n % OR (CI) p-value
GG 58 71.6 47 58 1.82 (0.95-3.51) 0.07
AG 6 7.4 15 18.5 0.35 (0.13-0.96) 0.035*
AA 17 21 19 23.5 0.87 (0.41-1.82) 0.708
Allele
G 122 75.3 109 67.3 1.48 (0.91-2.41) 0.11
A 40 24.7 53 32.7 0.67 (0.41-1.09) 0.11
HS: hemorrhagic stroke; *significant p < 0.05.
taBLE 3 − Clinical characteristics of case and control subjects
TNFA -308G/A
    GG     AG + AA    
    Aneurysm/HS Control     Aneurysm/HS Control    
    n % n % OR (CI) p-value n % n % OR (CI) p-value
SAH
Yes 41 70.7 7 14.9
13.78 (5.16-36.79) < 0.001*
19 82.6 1 2.9
156.75 (16.31-1506.47) < 0.001*
No 17 29.3 40 85.1 4 17.4 33 97.1
Smoking status
Yes 24 41.4 16 34
1.36 (0.61-3.04) 0.442
8 34.8 8 23.5
1.73 (0.54-5.57) 0.354
No 34 58.6 31 66 15 65.2 26 76.5
Alcohol consumption
Yes 15 25.9 10 21.3
1.29 (0.52-3.21) 0.584
7 30.4 10 29.4
1.05 (0.33-3.33) 0.92
No 43 74.1 37 78.7 16 69.6 24 70.6
HS: hemorrhagic stroke; SAH: systemic arterial hypertension; OD: odds ratio; CI: confidence interval; *significant p < 0.05.
Traditional cerebrovascular risk factors were analyzed, 
such as history of hypertension, smoking status and alcohol 
consumption. According to the collected data, a history of 
systemic arterial hypertension (SAH) was found more often in 
cases than in control individuals (both p < 0.001), both in the 
absence of allele A (cases 70.7% vs. 14.9%) and the presence 
of the allele A (82.6% vs. 2.9%). Besides increasing the risk 
of aneurysm or HS, independently of the presence or absence 
of the A allele (GG: OR = 13.78, CI = 5.16-36.79; GA + AA: OR = 
156.75, CI = 16.31-1506.47). However, smoking status and 
alcohol consumption (GG: p = 0.584; AG + AA: p = 0.920) 
(GG: p = 0.442; AG + AA: p = 0.354) did not show statistical 
significance between case and control groups, independent of 
the presence or absence of the A allele (Table 3).
For the TNFA -308G/A polymorphism analysis in relation 
to different scales that measure severity, stage and incapacity 
of patients, the AG and AA genotypes were combined in a 
single group for comparison with the GG genotype. No specific 
association was found between Glasgow scale, Barthel index 
and Rankin scale and the presence of different genotypes 
(Table 4).
According to the logistic regression analysis, the binary 
factors were considered: SAH, smoking status, alcohol 
consumption and Rankin scale (RS) did not remain 
significant factors, only the constant was statistically 
significant (Table 5).
In Table 6, there was no association between the TNFA 
-308G/A polymorphism genotypes and the presence of changes 
in the neuroimaging (p = 0.371). The most common change in 
neuroimaging was subarachnoid hemorrhage, both in the 
GG genotype and in the AG + AA genotypes, 48.7% and 12.8%, 
respectively.
taBLE 1 − Association of TNFA -308G/A (rs1800629) 
polymorphism with HS or aneurysm
Aneurysm HS Control
n % n % n % p-value
GG 21 63.6 37 77.1 47 58 0.09
AG 3 9.1 3 6.3 15 18.5 0.102
AA 9 27.3 8 16.7 19 23.5 0.493
Allele
G 45 68.2 77 80.2 109 67.3 0.07
A 21 31.8 19 19.8 53 32.7
HS: hemorrhagic stroke.
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taBLE 5 − Multivariate logistic regression for genotyping (presence of GG genotype) according to the factors included in the model




Systemic arterial hypertension (1) 0.659 0.667 0.974 1 0.324 1.933 0.522 7.15
Smoking status(1) -0.012 0.56 0 1 0.984 0.988 0.33 2.965
Alcohol consumption(1) 0.316 0.558 0.321 1 0.571 1.372 0.459 4.098
Rankin scale(1) 0.631 0.722 0.762 1 0.383 1.879 0.456 7.74
Constant -1.603 0.723 4.91 1 0.027* 0.201
a insert variables on step 1: SAH, smoking status, alcohol consumption, Rankin scale; *significant p < 0.05.
SAH: systemic arterial hypertension; CI: confidence interval.
taBLE 6 − Association between TNFA -308G/A (rs1800629) polymorphism 
genotypes and neuroimaging of case group
GG AG + AA
n % n % p-value
Middle cerebral artery 8 20.5 4 10.3
0.371
Right frontal parietal cavernous hemangioma 0 0 1 2.6
Aneurysm clip with post-surgery infection 1 2.6 0 0
Left temporal intraparenchymal hematoma 3 7.7 3 7.7
Subarachnoid hemorrhage 19 48.7 5 12.8
Diffuse subarachnoid hemorrhage 1 2.6 0 0
Thalamic hemorrhage with ventricular flood 1 2.6 0 0
Expansive point angle lesion 3 7.7 0 0
Basal ganglia 3 7.7 0 0
taBLE 4 − Association between TNFA -308G/A (rs1800629) polymorphism 
genotypes and outcome in case group by Glasgow scale, 
Rankin scale and Barthel index  
GG AG + AA
n % n % p
Glasgow
Intermediate coma 5 8.6 3 13
0.644Superficial coma 1 1.7 1 4.3
Normality 52 89.7 19 82.6
Rankin scale
No symptoms at all 17 29.3 3 13
0.091
No significant symptoms 32 55.2 14 60.9
Slight disability 2 3.4 0 0
Moderate disability 1 1.7 2 8.7
Moderately severe disability 5 8.6 1 4.3
Severe disability 1 1.7 3 13
Barthel index  
Severe disability 6 10.3 4 17.4
0.778
Moderate disability 5 8.6 1 4.3
Slight disability 28 48.3 11 47.8
Functional independence 19 32.8 7 30.4
DiSCuSSion
This is the first report to evaluate the influence of TNFA  -308G/
A polymorphism upon the risk of HS or aneurysm in a Brazilian 
population. Part of the results shows a protective effect in the AG 
genotype patients; this same effect was verified in a Chinese population 
with the AG genotype(21). Author implied that it might indirectly 
explain the high serum level of the cytokine TNF-α previously 
reported in ischemic stroke cases(21). However, it differs from a more 
recent study in which TNFA -308G/A gene polymorphisms seem to 
not contribute to the risk of ischemic stroke(22). 
Furthermore, we confirmed that history of hypertension 
increases the risk of HS or aneurysm, independently of A allele 
absence or presence. This association is already well known and 
documented(23-26). 
This is the first study to demonstrate associations between 
stroke or aneurysm functional outcome and TNFA -308G/A 
polymorphism. Our results find no association using the 
incapacity status scales.
ConCLuSion
In summary, the findings of this work show that the TNFA 
-308 AG genotype is associated with a decreased risk of aneurysm 
or HS. The present study has some limitations. All patients and 
control subjects were selected from one hospital, thus there 
may be some selection bias. Besides that, other polymorphisms 
and genetic alterations may influence the development of 
aneurysm or HS. Therefore, conducting additional studies 
incorporating a large number of subjects might clarify the 
association between TNFA -308G/A polymorphism and the risk 
of aneurysm or HS.
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